James Lankford actually said...

"I would be glad to be able to get that, because that may broaden out and accelerate some of the process as well."

"How do you all deal with the moral issues and the ethical issues of leaving those that are getting the placebo--knowing that they are in a terminal status, as opposed to trying to shift them over?"

"OK. Talk to me about the internal conversation about acceptable risk."

"There is a difference between effective and duplicative."